Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies

References

• Sehgal A, Price JL, Man B, Young MW. Loss of circadian behavioral rhythms and per RNA oscillations in the drosophila mutant timeless. Science. 1994;263(5153):1603–1606.
   PubMed Web of Science ®Google Scholar
• Vitaterna MH, King DP, Chang A-M, Kornhauser JM, Lowrey PL, McDonald JD, Dove WF, Pinto LH, Turek FW, Takahashi JS. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behaviour. Science. 1994;264(5159):719–725.
   PubMed Web of Science ®Google Scholar
• van der Horst GT, Muijtjens M, Kobayashi K, Takano R, Kanno S, Takao M, de Wit J, Verkerk A, Eker AP, van Leenen D, Buijs R, Bootsma D, Hoeijmakers JH, Yasui A. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature. 1999;398(6728):627–630.
   PubMed Web of Science ®Google Scholar
• Okamura H, Miyake S, Sumi Y, Yamaguchi S, Yasui A, Muijtjens M, Hoeijmakers JHJ, van der Horst GTJ. Photic induction of mPer1 and mPer2 in Cry-deficient mice lacking a biological clock. Science.1999;286(5449):2531–2534.
   PubMed Web of Science ®Google Scholar
• Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell. 2000;103:1009–1017.
   PubMed Web of Science ®Google Scholar
• Yu EA, Weaver DR. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany, NY). 2011;3(5):479–493.
   PubMedGoogle Scholar
• King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP, Steeves TDL, Vitaterna MH, Kornhauser JM, Lowrey PL, Turek FW, Takahashi JS. Positional cloning of the mouse circadian clock gene. Cell. 1997;89:641–653.
   PubMed Web of Science ®Google Scholar
• Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J. Obesity and metabolic syndrome in circadian clock mutant mice. Science. 2005;308(5724):1043–1045.
   PubMed Web of Science ®Google Scholar
• Dubrovsky YV, Samsa WE, Kondratov RV. Deficiency of circadian protein clock reduces lifespan and increases age-related cataract development in mice. Aging (Albany NY). 2010; 2(12):936–944.
   PubMedGoogle Scholar
• Dolatshad H, Campbell EA, O’Hara L, Maywood ES, Hastings MH, Johnson MH. Developmental and reproductive performance in circadian mutant mice. Hum Reprod. 2006;21:68–79.
   PubMed Web of Science ®Google Scholar
• Kennaway DJ, Boden MJ, Voultsios A. Reproductive performance in female clock Delta19 mutant mice. Reprod Fertil Dev. 2004;16:801–810.
   PubMed Web of Science ®Google Scholar
• McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DI, Nestler EJ. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci USA. 2005;102:9377–9381.
   PubMed Web of Science ®Google Scholar
• Antoch MP, Gorbacheva VY, Vykhovanets O, Toshkov IA, Kondratov RV, Kondratova AA, Lee C, Nikitin AY. Disruption of the circadian clock due to the clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle. 2008;7:1197–1204.
   PubMed Web of Science ®Google Scholar
• Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, Ivanova G, Omura C, Mo S, Vitaterna MH, Lopez JP, Philipson LH, Bradfield CA, Crosby SD, JeBailey L, Wang X, Takahashi JS, Bass J. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010;466(7306):627–631.
   PubMed Web of Science ®Google Scholar
• Kondratov RV, Kondratova AA, Lee C, Gorbacheva VY, Chernov MV, Antoch MP. Post-translational regulation of circadian transcriptional CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES. Cell Cycle. 2006;5(8):890–895.
   PubMed Web of Science ®Google Scholar
• Alvarez JD, Hansen A, Ord T, Bebas P, Chappell PE, Giebultowicz JM. Williams C Moss S, Sehgal A. The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice. J Biol Rhythms. 2008;23(1):26–36.
   PubMed Web of Science ®Google Scholar
• Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One. 2010;5:e10995.
   PubMed Web of Science ®Google Scholar
• Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM, Hitomi K, Thresher RJ, Ishikawa T, Miyazaki J, Takahashi JS, Sancar A. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA. 1999; 96(21):12114–12119.
   PubMed Web of Science ®Google Scholar
• Shearman LP, Jin X, Lee C, Reppert SM, Weaver DR. Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol. 2000;20:6269–6275.
   PubMed Web of Science ®Google Scholar
• Feillet CA, Ripperger JA, Magnone MC, Dulloo A, Albrecht U, Challet E. Lack of food anticipation in Per2 mutant mice. Curr Biol. 2006;16(20):2016–2022.
   Web of Science ®Google Scholar
• Feillet CA, Albrecht U, Challet EJ. ‘Feeding time’ for the brain: a matter of clocks. Physiol Paris. 2006;100(5–6):252–260.
   PubMed Web of Science ®Google Scholar
• Lee CC. The circadian clock and tumor suppression by mammalian period genes. Methods Enzymol. 2005;393,852–861.
   PubMed Web of Science ®Google Scholar
• Chen-Goodspeed M, Lee CC. Tumor suppression and circadian function. J Biol Rhythms. 2007;22(4):291–298.
   PubMed Web of Science ®Google Scholar
• Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci USA. 2009;106(8):2841–2846.
   PubMed Web of Science ®Google Scholar
• Khalil HS, Petkova R, Zhelev N. Differential genetic advantages in youth and in aging, or how to die healthy. Biotechnol Biotechnol Equipment. 2012;26(1):2703–2711.
   Web of Science ®Google Scholar
• Rensing L, Meyer-Grahle U, Ruoff P. Biological timing and the clock metaphor: oscillatory and hourglass mechanisms. Chronobiol Int. 2001;18(3):329–369.
   PubMed Web of Science ®Google Scholar
• Petkova R, Chicheva Z, Chakarov S. Measuring telomere length – from ends to means. Biotechnol Biotechnol Equipment. 2011;25(4):2576–2582.
   Web of Science ®Google Scholar
• Chicheva Z, Chelenkova P, Petkova R, Chakarov S. Children of the Sun, children of the Moon – a mini-panel for assessment of inter-individual variation between the capacity of healthy individuals to repair everyday genotoxic insults. Biotechnol Biotechnol Equipment. 2012;26(4):3142–3147.
   Web of Science ®Google Scholar
• Kunieda T, Minamino T, Katsuno T, Tateno K, Nishi J, Miyauchi H, Orimo M, Okada S, Komuro I. Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ Res. 2006;98(4):532–539.
   PubMed Web of Science ®Google Scholar
• Qu Y, Mao M, Li X, Liu Y, Ding J, Jiang Z, Wan C, Zhang L, Wang Z, Mu D. Telomerase reconstitution contributes to resetting of circadian rhythm in fibroblasts. Mol Cell Biochem. 2008;313(1–2):11–18.
   PubMed Web of Science ®Google Scholar
• Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu Y-H. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291(5506):1040–1043.
   PubMed Web of Science ®Google Scholar
• Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, Honma K. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002;419(6909):841–844.
   PubMed Web of Science ®Google Scholar
• He Y, Jones CR, Fujiki N, Xu Y, Guo B, Holder JL Jr, Rossner MJ, Nishino S, Fu Y-H. The transcriptional repressor DEC2 regulates sleep length in mammals. Science. 2009;325(5942):866–870.
   PubMed Web of Science ®Google Scholar
• Kissling C, Retz W, Wiemann S, Coogan AN, Clement RM, Hünnerkopf R, Conner AC, Freitag CM, Rösler M, Thome J. A polymorphism at the 3′-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatric Genet. 2008;147(3):333–338.
   PubMed Web of Science ®Google Scholar
• Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Stravopodis DJ, Bramis K, Lymperi M, Pektasidis D. Association of the clock genes polymorphisms with colorectal cancer susceptibility. J Surg Oncol. 2013;108(8):563–567.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev. 2005;14(1):268–270.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Leaderer D, Guss C, Brown HN, Zhang Y, Boyle P, Stevens RG, Hoffman A, Qin Q, Han X, Zheng T. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer. 2007;120(2):432–435.
   PubMed Web of Science ®Google Scholar
• Petkova R, Chakarov S, Ganev V. Genetic bases for predisposition to common multifactorial disease in man. Part I. Biotechnol Biotechnol Equipment. 2007; 21(3):286–293.
   Web of Science ®Google Scholar
• Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17(1):108–111.
   PubMed Web of Science ®Google Scholar
• Hansen J, Lassen CF. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med. 2012;69(8):551–556.
   PubMed Web of Science ®Google Scholar
• Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW. Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey. J Natl Cancer Inst. 2013;105(17):1292–1297.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Feskanich D, Liang G, Han J. Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol. 2013;178(9):1434–1441.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(5):872–879.
   PubMed Web of Science ®Google Scholar
• Petkova R, Chakarov S, Ganev V. Genetic bases for predisposition to common multifactorial disease in man. Part II. Biotechnol Biotechnol Equipment. 2007;21(4):385–392.
   Web of Science ®Google Scholar
• Kloog I, Haim A, Stevens RG, Barchana M, Portnov BA. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int. 2008;25(1):65–81.
   PubMed Web of Science ®Google Scholar
• Feychting M, Osterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology. 1998;9(5):490–494.
   PubMedGoogle Scholar
• Kliukiene J, Tynes T, Andersen A. Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer. 2001;84(3):397–399.
   PubMed Web of Science ®Google Scholar
• Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley S. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009;20(9):1753–1756.
   PubMed Web of Science ®Google Scholar
• Pukkala E, Ojamo M, Rudanko SL, Stevens RG, Verkasalo PK. Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment? Cancer Causes Control. 2006;17(4):573–576.
   PubMed Web of Science ®Google Scholar
• Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med. 2012;18:1249–1260.
   PubMed Web of Science ®Google Scholar
• Schwimmer H, Metzer A, Pilosof Y, Szyf M, Machnes ZM, Fares F, Harel O, Haim A. Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation. Chronobiol Int. 2014;31(1):144–150.
   PubMed Web of Science ®Google Scholar
• Hahm BJ, Jo B, Dhabhar FS, Palesh O, Aldridge-Gerry A, Bajestan SN, Neri E, Nouriani B, Spiegel D, Zeitzer JM. Bedtime misalignment and progression of breast cancer. Chronobiol Int. 2014;31(2):214–221.
   PubMed Web of Science ®Google Scholar
• Kvaskoff M, Weinstein P. Are some melanomas caused by artificial light? Med Hypotheses. 2010;75(3):305–311.
   PubMed Web of Science ®Google Scholar
• Kuo SJ, Chen ST, Yeh KT, Hou MF, Chang YS, Hsu NC, Chang JG. Disturbance of circadian gene expression in breast cancer. Virchows Arch. 2009;454(4):467–474.
   PubMed Web of Science ®Google Scholar
• Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, Nozaki A, Numata K, Shiozawa M, Rino Y, Tanaka K, Masuda M, Imada T. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep. 2011;25(5):1439–1446.
   PubMed Web of Science ®Google Scholar
• Mannic T, Meyer P, Triponez F, Pusztaszeri M, Le Martelot G, Mariani O, Schmitter D, Sage D, Philippe J, Dibner C. Circadian clock characteristics are altered in human thyroid malignant nodules. J Clin Endocrinol Metab. 2013;98(11):4446–4456.
   PubMed Web of Science ®Google Scholar
• Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y. Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer. 2000;27:169–176.
   PubMed Web of Science ®Google Scholar
• Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33(1):149–155.
   PubMed Web of Science ®Google Scholar
• Mazzoccoli G, Piepoli A, Carella M, Panza A, Pazienza V, Benegiamo G, Palumbo O, Ranieri E. Altered expression of the clock gene machinery in kidney cancer patients. Biomed Pharmacother. 2012;66(3):175–179.
   PubMed Web of Science ®Google Scholar
• Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA. Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg. 2013;17(3):443–450.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu XY, Han J, Liu KY, Liao JW, Xu RH, Zou QF. Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. Int J Clin Exp Pathol. 2014;7(2):619–630.
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009;117(2):423–431.
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Ansell CM, Quiton DF, Oh EY, Du-Quiton J, Hrushesky WJ. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009;26(7):1323–1339.
   PubMed Web of Science ®Google Scholar
• Miyazaki K, Wakabayashi M, Hara Y, Ishida N. Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells. 2010;15(4):351–358.
   PubMed Web of Science ®Google Scholar
• Rana S, Munawar M, Shahid A, Malik M, Ullah H, Fatima W, Mohsin S, Mahmood S. Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. Mol Biol Rep. 2014;41(1):95–103.
   PubMed Web of Science ®Google Scholar
• Eisele L, Prinz R, Klein-Hitpass L, Nückel H, Lowinski K, Thomale J, Moeller LC, Dührsen U, Dürig J. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol. 2009;83(4):320–327.
   PubMed Web of Science ®Google Scholar
• Hanoun M, Eisele L, Suzuki M, Greally JM, Hüttmann A, Aydin S, Scholtysik R, Klein-Hitpass L, Dührsen U, Dürig J. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One. 2012;7(3):e34347.
   PubMed Web of Science ®Google Scholar
• Winkler D, Döhner H, Stilgenbauer S. Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia. Curr Drug Targets. 2006;7(10):1313–1327.
   PubMed Web of Science ®Google Scholar
• Tummala H, Goltsov A, Khalil HS, Sproul A, Scott F, Mitev V, Zhelev N. Advocating the need of a systems biology approach for personalised prognosis and treatment of B-CLL patients. Biodiscovery. 2012;6:4.
   Google Scholar
• Zeng ZL, Luo HY, Yang J, Wu WJ, Chen DL, Huang P, Xu RH. Overexpression of the circadian clock gene bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res. 2014;20(4):1042–1052.
   PubMed Web of Science ®Google Scholar
• Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y, Liu R, Huang W. Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One. 2013;8(4):e61679.
   PubMed Web of Science ®Google Scholar
• Khalil HS, Tummala H, Chakarov S, Zhelev N, Lane DP. Targeting ATM pathway for therapeutic intervention in cancer. Biodiscovery. 2012;1:3.
   Google Scholar
• Yang X, Wood PA, Hrushesky WJ. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem. 2010;285(5):3030–3034.
   PubMed Web of Science ®Google Scholar
• Idowu MA, Khalil HS, Bown JL, Zhelev N. Reverse engineering of drug induced DNA damage response signalling pathway reveals dual outcomes of ATM kinase inhibition. Biodiscovery. 2013;9:4.
   Google Scholar
• Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer. 2003;97(1):155–169.
   PubMed Web of Science ®Google Scholar
• Petkova R, Chelenkova P, Georgieva E, Chakarov S. What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part I – role of individual repair capacity in the constitution of risk for late-onset multifactorial disease. Biotechnol Biotechnol Equipment. 2013;27(6):4208–4216.
   Web of Science ®Google Scholar
• Klevecz R, Braly P. Circadian and ultradian cytokinetic rhythms of spontaneous human cancer. Ann NY Acad Sci. 1991;618:257–276.
   PubMed Web of Science ®Google Scholar
• Smaaland R, Lote K, Sothern RB, Laerum OD. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Cancer Res. 1993;53(13):3129–3138.
   PubMed Web of Science ®Google Scholar
• Tampellini M, Filipski E, Liu XH, Lemaigre G, Li XM, Vrignaud P, François E, Bissery MC, Lévi F. Docetaxel chronopharmacology in mice. Cancer Res. 1998;58(17):3896–3904.
   PubMed Web of Science ®Google Scholar
• Granda TG, D’Attino RM, Filipski E, Vrignaud P, Garufi C, Terzoli E, Bissery MC, Lévi F. Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma. Br J Cancer. 2002;86(6):999–1005.
   PubMed Web of Science ®Google Scholar
• Granda TG, Lévi F. Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int. 2002;19:21–41.
   PubMed Web of Science ®Google Scholar
• Chakarov S, Stoilov P, Alexandrov A, Russev G. Repair pattern in the beta-globin gene cluster of human fibroblasts after ultraviolet irradiation. Eur J Biochem. 1997;248:669–675.
   PubMedGoogle Scholar
• Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649–666.
   PubMed Web of Science ®Google Scholar
• Chelenkova P, Petkova R, D’ Ascanio I, Zhelev N, Chakarov S. In sickness and in health: a set of markers for individual repair capacity in risk assessment, monitoring and prognosis of human disease. Curr Opin Biotechnol. 2013;24(suppl. 1):S105.
   PubMed Web of Science ®Google Scholar
• Boone DR, Sell SL, Micci MA, Crookshanks JM, Parsley M, Uchida T, Prough DS, DeWitt DS, Hellmich HL. Traumatic brain injury-induced dysregulation of the circadian clock. PLoS One. 2012;7(10):e46204.
   PubMed Web of Science ®Google Scholar
• Hatfield CF, Herbert J, van Someren EJ, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain. 2004;127(Pt 5):1061–1074.
   PubMed Web of Science ®Google Scholar
• Wu YH, Fischer DF, Kalsbeek A, Garidou-Boof ML, van der Vliet J, van Heijningen C, Liu RY, Zhou JN, Swaab DF. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the master clock. FASEB J. 2006;20(11):1874–1876.
   PubMed Web of Science ®Google Scholar
• Maemura K, de la Monte SM, Chin MT, Layne MD, Hsieh CM, Yet SF, Perrella MA, Lee ME. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem. 2000;275:36847–36851.
   PubMed Web of Science ®Google Scholar
• Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S, Shimeno H. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res. 2003;63:7277–7283.
   PubMed Web of Science ®Google Scholar
• Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29(5):992–996.
   PubMed Web of Science ®Google Scholar
• Willich SN. Circadian variation and triggering of cardiovascular events. Vasc Med. 1999;4(1):41–49.
   PubMed Web of Science ®Google Scholar
• Karmarkar SW, Tischkau SA. Influences of the circadian clock on neuronal susceptibility to excitotoxicity. Front Physiol. 2013;4:313.
   Google Scholar
• Wiebking N, Maronde E, Rami A. Increased neuronal injury in clock gene Per-1 deficient-mice after cerebral ischemia. Curr Neurovasc Res. 2013;10(2):112–125.
   PubMedGoogle Scholar
• Tischkau SA, Cohen JA, Stark JT, Gross DR, Bottum KM. Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. Exp Neurol. 2007;208(2):314–322.
   PubMed Web of Science ®Google Scholar
• Cavalcanti PR, Campos TF, Araüjo JF. Circadian and homeostatic changes of sleep-wake and quality of life in stroke: implications for neurorehabilitation. Neurorehabilitation. 2013;32(2):337–343.
   PubMed Web of Science ®Google Scholar
• Chelenkova P, Petkova R, Chamova T, Zheliazkova-Glaveeva S, Tournev I, Chakarov S. Homozygous carriership of the wildtype allele of the XPCins83 polymorphism is an independent protective factor against cerebrovascular incidents in the Bulgarian population. Compt Rend Acad Bulgarian Sci. 2014;67(2):263–268.
   Web of Science ®Google Scholar
• Leproult R, Holmbäck U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014;63(6).
   PubMed Web of Science ®Google Scholar
• Gale JE, Cox HI, Qian J, Block GD, Colwell CS, Matveyenko AV. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. J Biol Rhythms. 2011;26(5):423–433.
   PubMed Web of Science ®Google Scholar
• Rakshit K, Thomas AP, Matveyenko AV. Does disruption of circadian rhythms contribute to Beta-cell failure in type 2 diabetes? Curr Diab Rep. 2014;14(4):474.
   PubMed Web of Science ®Google Scholar